Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

February 2004 (Volume 43, Supplement 1)   [Index by Author] 
 
       Articles
 
The LOX/COX pathway: challenging the management of osteoarthritis

Supported by an restricted educational grant from Merckle GmbH and its EuroAlliance Partners Alfa Wassermann S.p.A and Lácer S.A.
 



To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles:

G. R. Burmester
Introduction
Rheumatology 2004 43: i1-i3; doi:10.1093/rheumatology/keh101 [PDF]  

F. C. Breedveld
Osteoarthritis—the impact of a serious disease
Rheumatology 2004 43: i4-i8; doi:10.1093/rheumatology/keh102 [Abstract] [PDF]  

S. Laufer
Osteoarthritis therapy—are there still unmet needs?
Rheumatology 2004 43: i9-i15; doi:10.1093/rheumatology/keh103 [Abstract] [PDF]  

K. Brune
Safety of anti-inflammatory treatment—new ways of thinking
Rheumatology 2004 43: i16-i20; doi:10.1093/rheumatology/keh104 [Abstract] [PDF]  

J. M. Alvaro-Gracia
Licofelone—clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis
Rheumatology 2004 43: i21-i25; doi:10.1093/rheumatology/keh105 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.